KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53.
Saved in:
| Title: | KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53. |
|---|---|
| Authors: | Tolosa EJ; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Raja Arul GL; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA; Molecular Pharmacology and Experimental Therapeutics Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA., Sigafoos AN; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Ferrero V; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Pease DR; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Almada LL; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Vera RE; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Pena Ruiz NM; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA; Molecular Pharmacology and Experimental Therapeutics Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA., Hogenson TL; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., LaRue-Nolan KC; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA; Molecular Pharmacology and Experimental Therapeutics Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA., Tader BR; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Graham RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Brown M; Division of Endocrinology, Metabolism, Diabetes, and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA., Hagen CE; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Matveyenko AV; Division of Endocrinology, Metabolism, Diabetes, and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA., Carr RM; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Ge K; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA., Fernandez-Zapico ME; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: FernandezZapico.Martin@mayo.edu. |
| Source: | The Journal of biological chemistry [J Biol Chem] 2026 May 27; Vol. 302 (7), pp. 113203. Date of Electronic Publication: 2026 May 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42208891 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tolosa+EJ%22">Tolosa EJ</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Raja+Arul+GL%22">Raja Arul GL</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA; Molecular Pharmacology and Experimental Therapeutics Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Sigafoos+AN%22">Sigafoos AN</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Ferrero+V%22">Ferrero V</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Pease+DR%22">Pease DR</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Almada+LL%22">Almada LL</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Vera+RE%22">Vera RE</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Pena+Ruiz+NM%22">Pena Ruiz NM</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA; Molecular Pharmacology and Experimental Therapeutics Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Hogenson+TL%22">Hogenson TL</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22LaRue-Nolan+KC%22">LaRue-Nolan KC</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA; Molecular Pharmacology and Experimental Therapeutics Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Tader+BR%22">Tader BR</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Graham+RP%22">Graham RP</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Brown+M%22">Brown M</searchLink>; Division of Endocrinology, Metabolism, Diabetes, and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Hagen+CE%22">Hagen CE</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Matveyenko+AV%22">Matveyenko AV</searchLink>; Division of Endocrinology, Metabolism, Diabetes, and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Carr+RM%22">Carr RM</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Ge+K%22">Ge K</searchLink>; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Fernandez-Zapico+ME%22">Fernandez-Zapico ME</searchLink>; Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: FernandezZapico.Martin@mayo.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985121R%22">The Journal of biological chemistry</searchLink> [J Biol Chem] 2026 May 27; Vol. 302 (7), pp. 113203. <i>Date of Electronic Publication: </i>2026 May 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%2E+on+behalf+of+American+Society+for+Biochemistry+and+Molecular+Biology%22">Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2985121R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1083-351X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219258%22">00219258 </searchLink><i>NLM ISO Abbreviation: </i>J Biol Chem <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42208891 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jbc.2026.113203 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 113203 Titles: – TitleFull: KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tolosa EJ – PersonEntity: Name: NameFull: Raja Arul GL – PersonEntity: Name: NameFull: Sigafoos AN – PersonEntity: Name: NameFull: Ferrero V – PersonEntity: Name: NameFull: Pease DR – PersonEntity: Name: NameFull: Almada LL – PersonEntity: Name: NameFull: Vera RE – PersonEntity: Name: NameFull: Pena Ruiz NM – PersonEntity: Name: NameFull: Hogenson TL – PersonEntity: Name: NameFull: LaRue-Nolan KC – PersonEntity: Name: NameFull: Tader BR – PersonEntity: Name: NameFull: Graham RP – PersonEntity: Name: NameFull: Brown M – PersonEntity: Name: NameFull: Hagen CE – PersonEntity: Name: NameFull: Matveyenko AV – PersonEntity: Name: NameFull: Carr RM – PersonEntity: Name: NameFull: Ge K – PersonEntity: Name: NameFull: Fernandez-Zapico ME IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 05 Text: 2026 May 27 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1083-351X Numbering: – Type: volume Value: 302 – Type: issue Value: 7 Titles: – TitleFull: The Journal of biological chemistry Type: main |
| ResultId | 1 |